Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 94751-94800 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04955834
A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes
PHASE3
Recruiting
344 participants
Started: Jul 27, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
2 locations
NCT04852432
Evaluation of the Efficacy of Oxygen Therapy and Clinical Feasibility of High Flow Nasal Cannula During Moderate and Deep Sedation in Pediatric Patients
NA
Recruiting
258 participants
Started: Jul 27, 2021 · Completed: Dec 30, 2024
1 condition
1 sponsor
1 location
NCT04926922
PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia
N/A
Active, not recruiting
200 participants
Started: Jul 27, 2021 · Completed: Jun 7, 2026
2 conditions
1 sponsor
5 locations
NCT05062278
Vinblastine for Leukoreduction in Newly Diagnosed AML and Hyperleukocytosis
PHASE2
Recruiting
46 participants
Started: Jul 26, 2021 · Completed: Dec 1, 2025
2 conditions
1 sponsor
1 location
NCT04776681
Living With Marfans and Your Aorta: Surgical Outcomes Study
N/A
Recruiting
28 participants
Started: Jul 26, 2021 · Completed: Sep 30, 2025
2 conditions
3 sponsors
1 location
NCT04995224
Mechanism of Chronic Pain in Patients With IBD
N/A
Recruiting
25,600 participants
Started: Jul 26, 2021 · Completed: Dec 31, 2025
1 condition
8 sponsors
1 location
NCT04823897
A Study of CCI-001 in Patients With Recurrent and/or Metastatic Solid Tumours
PHASE1
Recruiting
70 participants
Started: Jul 26, 2021 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT04982835
M6®-C Artificial Cervical Disc Two-Level IDE Pivotal Study
NA
Active, not recruiting
156 participants
Started: Jul 26, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
26 locations
NCT04541108
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
EARLY_PHASE1
Recruiting
15 participants
Started: Jul 26, 2021 · Completed: Dec 31, 2031
1 condition
1 sponsor
12 locations
NCT04570956
Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk
PHASE2
Active, not recruiting
65 participants
Started: Jul 26, 2021 · Completed: Dec 31, 2026
4 conditions
2 sponsors
3 locations
NCT05009329
A Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation in China
PHASE1/PHASE2
Active, not recruiting
311 participants
Started: Jul 26, 2021 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT01013714
Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias
PHASE3
Recruiting
40 participants
Started: Jul 26, 2021 · Completed: Aug 31, 2024
4 conditions
2 sponsors
3 locations
NCT04728607
Use of a Compression Device for Ring Removal: A Prospective Trial
NA
Active, not recruiting
50 participants
Started: Jul 26, 2021 · Completed: Nov 30, 2026
3 conditions
1 sponsor
1 location
NCT05650905
Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19
N/A
Recruiting
90 participants
Started: Jul 26, 2021 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05057312
Promoting HPV Vaccination Among Young Adults in Texas
NA
Active, not recruiting
1,200 participants
Started: Jul 26, 2021 · Completed: Jul 31, 2026
1 condition
2 sponsors
1 location
NCT04557891
Low-Intensity Focused Ultrasound Pulsation (LIFUP) for the Treatment of Generalized Anxiety Disorder (GAD)
NA
Recruiting
48 participants
Started: Jul 26, 2021 · Completed: Dec 31, 2025
1 condition
3 sponsors
3 locations
NCT04910568
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
PHASE1
Active, not recruiting
126 participants
Started: Jul 26, 2021 · Completed: Dec 10, 2025
1 condition
2 sponsors
27 locations
NCT04614168
Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes
NA
Active, not recruiting
17 participants
Started: Jul 26, 2021 · Completed: Dec 26, 2025
6 conditions
5 sponsors
1 location
NCT04609072
Connect for Cancer Prevention Study (Connect)
N/A
Recruiting
200,000 participants
Started: Jul 26, 2021 · Completed: Dec 31, 2070
2 conditions
1 sponsor
10 locations
NCT04831957
Hypothyroidism After the TAVI Procedure in Elderly Patients
NA
Recruiting
20 participants
Started: Jul 26, 2021 · Completed: Dec 31, 2050
2 conditions
1 sponsor
1 location
NCT04861051
Understanding Ketamine's Dissociative Effects (KD Study)
PHASE1
Recruiting
20 participants
Started: Jul 26, 2021 · Completed: Aug 1, 2028
1 condition
1 sponsor
1 location
NCT04589754
Adriamycin and Ifosfamide Combined With Sintilimab
PHASE2
Recruiting
176 participants
Started: Jul 26, 2021 · Completed: Jul 30, 2026
1 condition
1 sponsor
1 location
NCT05064553
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
N/A
Active, not recruiting
2,990 participants
Started: Jul 26, 2021 · Completed: Dec 31, 2026
5 conditions
1 sponsor
76 locations
NCT04934748
The GUARDIAN Trial - Vasopressor Sub-Study
PHASE4
Enrolling by invitation
6,254 participants
Started: Jul 25, 2021 · Completed: Apr 25, 2027
1 condition
1 sponsor
11 locations
NCT04884802
The GUARDIAN Trial
NA
Recruiting
6,254 participants
Started: Jul 25, 2021 · Completed: Apr 25, 2027
1 condition
1 sponsor
20 locations
NCT04934683
The GUARDIAN Trial - Induction Agent Sub-Study
PHASE4
Enrolling by invitation
6,254 participants
Started: Jul 25, 2021 · Completed: Apr 25, 2027
1 condition
1 sponsor
11 locations
NCT04282629
Cerebral Hemodynamic Optimization by Milrinone to Prevent Delayed Cerebral Ischemia
PHASE2
Recruiting
234 participants
Started: Jul 25, 2021 · Completed: Jul 31, 2025
1 condition
1 sponsor
5 locations
NCT04978012
Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line Chemotherapy
PHASE2
Recruiting
48 participants
Started: Jul 25, 2021 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05126446
the Aorta Arch Stent Graft System Combined With the Endovascular Needle System in Situ Fenestration
NA
Active, not recruiting
120 participants
Started: Jul 25, 2021 · Completed: Mar 30, 2028
1 condition
1 sponsor
1 location
NCT06629727
The Effect Of Virtual Reality Glasses On Pain And Anxiety During The Kidney Stone Lithotripsy Procedure
NA
Active, not recruiting
60 participants
Started: Jul 25, 2021 · Completed: Nov 10, 2024
3 conditions
1 sponsor
1 location
NCT04862286
Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977
PHASE3
Active, not recruiting
132 participants
Started: Jul 24, 2021 · Completed: Apr 30, 2028
1 condition
1 sponsor
41 locations
NCT04862429
Biopsy of Calcifications Under Contrast Enhancement Guide (BoCCE)
NA
Active, not recruiting
200 participants
Started: Jul 24, 2021 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT04867395
A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity
NA
Recruiting
282 participants
Started: Jul 23, 2021 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT04893525
Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments
PHASE2/PHASE3
Recruiting
658 participants
Started: Jul 23, 2021 · Completed: Jun 30, 2027
1 condition
1 sponsor
6 locations
NCT04915014
Sleeve Gastrectomy With Transit Bipartition(SG+TB) Versus Roux-en-Y Gastric Bypass (RYGB) for Type 3 Obesity
NA
Recruiting
320 participants
Started: Jul 23, 2021 · Completed: Jul 31, 2025
1 condition
2 sponsors
8 locations
NCT04906993
Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer
PHASE3
Active, not recruiting
443 participants
Started: Jul 23, 2021 · Completed: May 31, 2027
1 condition
1 sponsor
1 location
NCT04933721
Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies
PHASE3
Active, not recruiting
139 participants
Started: Jul 23, 2021 · Completed: Aug 31, 2031
2 conditions
1 sponsor
13 locations
NCT04830852
Pediatric COVID Outcomes Study (PECOS)
N/A
Active, not recruiting
5,000 participants
Started: Jul 23, 2021 · Completed: Jul 1, 2027
4 conditions
2 sponsors
2 locations
NCT05050643
High-Risk Veteran Initiative
NA
Active, not recruiting
17 participants
Started: Jul 23, 2021 · Completed: Dec 30, 2026
1 condition
7 sponsors
3 locations
NCT07073261
Prospective Multiethnic Validation of the Behçet's Syndrome Overall Damage Index (BODI)
N/A
Active, not recruiting
970 participants
Started: Jul 23, 2021 · Completed: Dec 30, 2027
1 condition
17 sponsors
1 location
NCT04918316
Initial Correction Keratoconus
NA
Active, not recruiting
32 participants
Started: Jul 23, 2021 · Completed: Sep 1, 2025
1 condition
1 sponsor
4 locations
NCT04580888
Emergency Echocardiography in Sepsis
NA
Active, not recruiting
312 participants
Started: Jul 23, 2021 · Completed: May 8, 2025
4 conditions
1 sponsor
10 locations
NCT04878029
Cabozantinib in Combination with Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer
PHASE1
Recruiting
32 participants
Started: Jul 23, 2021 · Completed: Dec 21, 2026
4 conditions
3 sponsors
1 location
NCT04922307
Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer
NA
Active, not recruiting
240 participants
Started: Jul 23, 2021 · Completed: Jun 15, 2027
1 condition
1 sponsor
3 locations
NCT04705818
Combining Epigenetic And Immune Therapy to Beat Cancer.
PHASE2
Active, not recruiting
173 participants
Started: Jul 23, 2021 · Completed: Dec 31, 2027
5 conditions
3 sponsors
3 locations
NCT04788615
Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS
PHASE3
Active, not recruiting
185 participants
Started: Jul 23, 2021 · Completed: Feb 13, 2026
1 condition
1 sponsor
41 locations
NCT04895735
MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer
PHASE2
Active, not recruiting
45 participants
Started: Jul 23, 2021 · Completed: Feb 28, 2028
4 conditions
1 sponsor
2 locations
NCT04797260
Phase I/II Clinical Trial Stem Cell Gene Therapy in RAG1-Deficient SCID
NA
Recruiting
10 participants
Started: Jul 23, 2021 · Completed: Dec 31, 2029
1 condition
3 sponsors
7 locations
NCT04530552
Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland
PHASE2
Active, not recruiting
34 participants
Started: Jul 23, 2021 · Completed: Jan 31, 2027
4 conditions
1 sponsor
5 locations
NCT04754412
Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study
NA
Recruiting
285 participants
Started: Jul 23, 2021 · Completed: Apr 1, 2026
22 conditions
2 sponsors
1 location
Previous
1
More pages
1893
1894
1895
1896
1897
1898
1899
More pages
2369
Next